Sai Life Sciences, Agility Life Sciences, and Centrix Pharma announce an ‘Integrated CMC Partnership’ to accelerate drug development for innovators

Sai Life Sciences, Agility Life Sciences, and Centrix Pharma Solutions have launched an Integrated CMC Partnership aimed at accelerating drug development for innovator biopharma companies. This strategic collaboration brings together the complementary strengths of the three organizations in Chemistry, Manufacturing and Controls (CMC), offering end-to-end services from API development to clinical manufacturing. The partnership provides integrated drug substance and drug product development, helping customers move efficiently from preclinical studies to first-in-human (FIH) clinical trials and beyond.